Voyager Therapeutics, Inc.
AAV SEROTYPES FOR BRAIN SPECIFIC PAYLOAD DELIVERY

Abstract:

The present disclosure relates to compositions, methods, and processes for the design, preparation, manufacture, use, and/or formulation of adeno-associated virus (AAV) particles for improved biodistribution and/or expression to particular regions of the central nervous system (CNS).